Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2006 | 12-2005 | 09-2005 | 06-2005 | 03-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,740,000 | 4,208,180 | 6,093,000 | 5,371,000 | 2,774,000 |
| Marketable Securities | 1,039,000 | 1,024,585 | 336,000 | 288,000 | 1,490,000 |
| Inventories | 2,347,000 | 2,176,444 | 2,200,000 | 2,168,000 | 2,130,000 |
| Other current assets | 482,000 | 5,478,595 | 412,000 | 410,000 | 421,000 |
| TOTAL | $13,944,000 | $13,173,735 | $13,895,000 | $13,120,000 | $11,805,000 |
| Non-Current Assets | |||||
| PPE Net | 6,767,000 | 6,650,214 | 6,332,000 | 6,225,000 | 6,130,000 |
| Intangibles | 4,046,000 | 4,078,000 | 2,975,000 | 2,896,000 | 2,811,000 |
| Other Non-Current Assets | 3,221,000 | 3,289,947 | 3,275,000 | 3,199,000 | 2,786,000 |
| TOTAL | $14,034,000 | $14,018,160 | $12,582,000 | $12,320,000 | $11,727,000 |
| Total Assets | $27,978,000 | $27,191,895 | $26,477,000 | $25,440,000 | $23,532,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 863,000 | 2,094,501 | 1,616,000 | 1,708,000 | 1,686,000 |
| Accounts payable and accrued liabilities | 4,931,000 | 818,854 | 4,579,000 | 4,272,000 | 4,155,000 |
| Other current liabilities | N/A | 6,561,878 | N/A | N/A | N/A |
| TOTAL | $9,346,000 | $9,508,940 | $9,431,000 | $9,142,000 | $9,140,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,288,000 | 5,269,959 | 5,212,000 | 5,212,000 | 4,083,000 |
| Other Non-Current Liabilities | 3,378,000 | 4,016,397 | 4,423,000 | 3,862,000 | 3,405,000 |
| TOTAL | $9,577,000 | $10,114,509 | $9,868,000 | $9,713,000 | $8,137,000 |
| Total Liabilities | $18,923,000 | $19,623,449 | $19,299,000 | $18,855,000 | $17,277,000 |
| Shareholders' Equity | |||||
| Common Shares | 1,494,000 | 1,490,675 | 1,487,000 | 1,486,000 | 1,485,000 |
| Retained earnings | 6,859,000 | 5,577,974 | 5,486,000 | 5,026,000 | 4,758,000 |
| Other shareholders' equity | -205,000 | -308,015 | -410,000 | -465,000 | -490,000 |
| TOTAL | $8,818,000 | $7,309,249 | $6,945,000 | $6,397,000 | $6,079,000 |
| Total Liabilities And Equity | $27,741,000 | $26,932,698 | $26,244,000 | $25,252,000 | $23,356,000 |